Carbapenemases in Enterobacteriaceae: Activity, Epidemiology, and Laboratory Detection

Clinical Microbiology Newsletter

Volumn 31, Issue 8, 2009, Pages 55-62

  Patel, Jean B ^a   Rasheed, J Kamile ^a   Kitchel, Brandon ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZTREONAM; BACTERIAL ENZYME; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEFALOTIN; CEFEPIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; KLEBSIELLA PNEUMONIAE CARBAPENEMASE; PENICILLIN DERIVATIVE; PIPERACILLIN; UNCLASSIFIED DRUG;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; ENTEROBACTERIACEAE; ENZYME ACTIVITY; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NONHUMAN; PSEUDOMONAS AERUGINOSA; UNITED STATES;

EID: 63249115755     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2009.03.005     Document Type: Article

References (81)

1. Bradford P.A., et al. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41 (1997) 563-569
2. Philippon A., Arlet A., and Jacoby G.A. Plasmid-determined AmpC-type b-lactamases. Antimicrob. Agents Chemother. 46 (2002) 1-11
3. Cornaglia G., et al. Diffusion of meropenem and imipenem through the outer membrane of Escherichia coli K-12 and correlation with their antibacterial activities. Antimicrob. Agents Chemother. 36 (1992) 1902-1908
4. Poirel L., et al. In vivo acquisition of high-level resistance to imipenem in Escherichia coli. J. Clin. Microbiol. 42 (2004) 3831-3833
5. Crowley B., Benedí V.J., and Doménech-Sánchez A. Expression of SHV-2 β-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems. Antimicrob. Agents Chemother. 46 (2002) 3679-3682
6. Livermore D.M., and Woodford N. The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 14 (2006) 413-420
7. Woodford N., et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-lactamase, KPC-3, in a New York medical center. Antimicrob. Agents Chemother. 48 (2004) 4793-4799
8. Bratu S., et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City. Arch. Intern. Med. 165 (2005) 1430-1435
9. Bradford P.A., et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City. Clin. Infect. Dis. 39 (2004) 55-60
10. Queenan A.M., and Bush K. Carbapenemases: the versatile β-lactamases. Clin. Microbiol. Rev. 20 (2007) 440-458
11. Yigit H., et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45 (2001) 1151-1161
12. Yigit H., et al. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing β-lactamase KPC-2. Antimicrob. Agents Chemother. 47 (2003) 3881-3889
13. Rasmussen B.A., et al. Characterization of IMI-1 β-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob. Agents Chemother. 40 (1996) 2080-2086
14. Queenan A.M., et al. SME-type carbapenem-hydrolyzing class A β-lactamases from geographically diverse Serratia marcescens strains. Antimicrob. Agents Chemother. 44 (2000) 3035-3039
15. Naas T., et al. Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A β-lactamase, Sme-1, from Serratia marcescens S6. Antimicrob. Agents Chemother. 38 (1994) 1262-1270
16. Walther-Rasmussen J., and Høiby N. Class A carbapenemases. J. Antimicrob. Chemother. 60 (2007) 470-482
17. Walsh T.R. The emergence and implications of metallo-β-lactamases in gram-negative bacteria. Clin. Microbiol. Infect. 11 (2005) 2-9
18. Walsh T.R., et al. Metallo-β-lactamases: the quiet before the stormβ Clin. Microbiol. Rev. 18 (2005) 306-325
19. Walther-Rasmussen J., and Høiby N. OXA-type carbapenemases. J. Antimicrob. Chemother. 57 (2006) 373-383
20. Lolans K., et al. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob. Agents Chemother. 50 (2006) 2941-2945
21. Perez F., et al. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51 (2007) 3471-3484
22. Poirel L., et al. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48 (2004) 15-22
23. Bonnet R., et al. Chromosome-encoded class D β-lactamase OXA-23 in Proteus mirabilis. Antimicrob. Agents Chemother. 46 (2002) 2004-2006
24. Yigit H., et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 52 (2008) 809
25. Robledo, I.E. et al. 2007. First report of a KPC-4 and CTX-M producing K. pneumoniae (Kp) isolated from Puerto Rico (PR), abstr. C2-1933, p. 142. In Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
26. Alba J., et al. Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing β-lactamase. Antimicrob. Agents Chemother. 49 (2005) 4760-4762
27. Bratu S., et al. Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York. Clin. Infect. Dis. 44 (2007) 972-975
28. Miriagou V., et al. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob. Agents Chemother. 47 (2003) 1297-1300
29. Mushtaq S., Ge G., and Livermore D.M. Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized β-lactamases. Antimicrob. Agents Chemother. 48 (2004) 1313-1319
30. Villegas M.V., et al. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob. Agents Chemother. 50 (2006) 2880-2882
31. Deshpande L.M., et al. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Entero bacteriaceae isolated in the United States Medical centers: report from the MYSTIC Program (1999-2005). Diagn. Microbiol. Infect. Dis. 56 (2006) 367-372
32. Hong T., et al. Escherichia coli: development of carbapenem resistance during therapy. Clin. Infect. Dis. 40 (2005) e84-e86
33. Navon-Venezia S., et al. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob. Agents Chemother. 50 (2006) 3098-3101
34. Villegas M.V., et al. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase. Antimicrob. Agents Chemother. 51 (2007) 1553-1555
35. Bratu S., et al. Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York. Antimicrob. Agents Chemother. 49 (2005) 776-778
36. Dortet L., et al. Intercontinental travels of patients and dissemination of plasmid-mediated carbapenemase KPC-3 associated with OXA-9 and TEM-1. J. Antimicrob. Chemother. 61 (2008) 455-457
37. Wolter D.J., et al. Detection of KPC carbapenem hydrolyzing β-lactamase in Pseudomonas aeruginosa (PA) from the Puerto Rico Medical Center Hospitals (PRMCHs), abstr. C2-1928. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother (2007), American Society for Microbiology, Washington, DC 141
38. Chiang T., et al. Identification of carbapenem-resistant Klebsiella pneumoniae harboring KPC enzymes in New Jersey. Microb. Drug Resist. 13 (2007) 235-239
39. Moland E.S., et al. Plasmid-mediated, carbapenem-hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J. Antimicrob. Chemother. 51 (2003) 711-714
40. Bratu S., et al. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob. Agents Chemother. 49 (2005) 3018-3020
41. Della-Latta, P. and S. Jenkins, personal communication.
42. Naas T., et al. Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob. Agents Chemother. 49 (2005) 4423-4424
43. Samra Z., et al. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int. J. Antimicrob. Agents 30 (2007) 525-529
44. Navon-Venezia S., et al. Emergence of an epidemic clone of KPC-3 producing carbapenem-resistant Klebsiella pneumoniae (KPC Kpn) in Israel closely related to an epidemic clone in the United States, abstr. C2-1931. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother (2007), American Society for Microbiology, Washington, DC 141
45. Wei Z.-Q., et al. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob. Agents Chemother. 51 (2007) 763-765
46. Cuzon G., et al. Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob. Agents Chemother. 52 (2008) 796-797
47. Monteiro J., et al. Carbapenem-resistant Klebsiella pneumoniae outbreak: emergence of KPC-2 producing strains in Brazil, abstr. C2-1929. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother (2007), American Society for Microbiology, Washington, DC 141
48. Hossain A., et al. Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp. Antimicrob. Agents Chemother. 48 (2004) 4438-4440
49. KPC-2 carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates. Antimicrob. Agents Chemother. 52 (2008) 2962-2965
50. Rasheed J.K., et al. Detection of the Klebsiella pneumoniae carbapenemase type 2 carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid. J. Clin Microbiol. 46 (2008) 2066-2069
51. KPC gene. Antimicrob. Agents Chemother. 52 (2008) 1257-1263
52. Kitchel B., et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae in the United States, abstr. C2-3730. Abstr. 48th Ann. ICAAC/IDSA 46th Ann. Meet (2008), American Society for Microbiology, Washington, DC
53. Naas T., Livermore D.M., and Nordmann P. Characterization of an LysR family protein, SmeR from Serratia marcescens S6, its effect on expression of the carbapenem-hydrolyzing β-lactamase Sme-1, and comparison of this regulator with other β-lactamase regulators. Antimicrob. Agents Chemother. 39 (1995) 629-637
54. Naas T., and Nordmann P. Analysis of a carbapenem-hydrolyzing class A β-lactamase from Enterobacter cloacae and its LysR-type regulatory protein. Proc. Natl. Acad. Sci. USA 91 (1994) 7693-7697
55. Nordmann P., et al. Biochemical properties of a carbapenem-hydrolyzing β-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob. Agents Chemother. 37 (1993) 939-946
56. Rasmussen B.A., and Bush K. Carbapenem-hydrolyzing β-lactamases. Antimicrob. Agents Chemother. 41 (1997) 223-232
57. Aubron C., et al. Carbapenemase-producing Enterobacteriaceae, U.S. rivers. Emerg. Infect. Dis. 11 (2005) 260-264
58. IMI-2 in an Enterobacter cloacae clinical isolate from China. Antimicrob. Agents Chemother. 50 (2006) 1610-1611
59. Ploy M.C., et al. Integrons: an antibiotic resistance gene capture and expression system. Clin. Chem. Lab. Med. 38 (2000) 483-487
60. IMP) in gram-negative rods resistant to broad-spectrum b-lactams. J. Clin. Microbiol. 34 (1996) 2909-2913
61. Shibata N., et al. PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J. Clin. Microbiol. 41 (2003) 5407-5413
62. Cornaglia G., et al. Appearance of IMP-1 metallo-β-lactamase in Europe. Lancet 353 (1999) 899-900
63. IMP allelic variants carried by gene cassettes of different phylogeny. Antimicrob. Agents Chemother. 44 (2000) 1229-1235
64. Hanson N.D., et al. First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-b-lactamase, IMP-18. Antimicrob. Agents Chemother. 50 (2006) 2272-2273
65. VIM-7, an evolutionarily distinct metallo-β-lactamase gene in a Pseudomonas aeruginosa isolate from the United States. Antimicrob. Agents Chemother. 48 (2004) 329-332
66. Lolans K., et al. First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-β-lactamase (VIM-2) in the United States. Antimicrob. Agents Chemother. 49 (2005) 3538-3540
67. VIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program. J. Clin. Microbiol. 45 (2007) 614-615
68. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. CLSI document M100-S18. CLSI, Wayne, PA.
69. Anderson K.F., et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J. Clin. Microbiol. 45 (2007) 2723-2725
70. Tenover F.C., et al. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg. Infect. Dis. 12 (2006) 1209-1213
71. IMP-8 in a university medical center in Taiwan. J. Clin. Microbiol. 39 (2001) 4433-4439
72. Tortola M.T., et al. First detection of a carbapenem-hydrolyzing metalloenzyme in two Enterobacteriaceae isolates in Spain. Antimicrob. Agents Chemother. 49 (2005) 3492-3494
73. Giakkoupi P., et al. Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates. J. Clin. Microbiol. 43 (2005) 494-496
74. Petropoulou D., et al. Evaluation of imipenem/imipenem+EDTA disk method for detection of metallo-β-lactamase-producing Klebsiella pneumoniae isolated from blood cultures. Microb. Drug Resist. 12 (2006) 39-43
75. Lee K., et al. Modified Hodge and EDTA-disk synergy tests to screen metallo-b-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin. Microbiol. Infect. 7 (2001) 88-91
76. Hong S.G., et al. Indirect Tris-EDTA (TE) disk test for detection of class A carbapenemase in clinical isolates, abstr. D-448. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother (2006), American Society for Microbiology, Washington, DC 144
77. Kim S.Y., et al. Convenient test using a combination of chelating agents for detection of metallo-β-lactamases in the clinical laboratory. J. Clin. Microbiol. 45 (2007) 2798-2801
78. Yan J.J., et al. Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-β-lactamases in gram-negative bacilli. Diagn. Microbiol. Infect. Dis. 49 (2004) 5-11
79. Arakawa Y., et al. Convenient test for screening metallo-β-lactamase-producing gram-negative bacteria by using thiol compounds. J. Clin. Microbiol. 38 (2000) 40-43
80. Walsh T.R., et al. Evaluation of a new Etest for detecting metallo-β-lactamases in routine clinical testing. J. Clin. Microbiol. 40 (2002) 2755-2759
81. VIM-2 allele-positive clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 43 (2005) 942-944